It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes
Results indicate that DSIP-CBBBP effectively modulates neurotransmitter levels, particularly 5-HT, glutamate, dopamine, and melatonin, leading to improved sleep quality compared to DSIP alone
This product is compounded utilizing corn-free sources to meet the individual needs of patients and is dispensed only with a valid prescription, emphasizing its status as a personalized medication that is not commercially available in standard retail pharmacies
However, peoples impairment lagged far behind, peaking about 5 hours after drinking alcohol even in participants well below the legal limit for driving under the influence (DUI)
Current research shows BPC-157 peptide therapy has a strong safety profile with minimal side effects